SUN PHARMACEUTICAL INDUSTRIES INC recalls DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufacture
Recalled June 17, 2026 · FDA recall D-0580-2026 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Presence of Particulate matter: Particulate matter identified as glass. · FDA Class I
Units
675 vials
Sold at
U.S. Nationwide
Description
Presence of Particulate matter: Particulate matter identified as glass.
Product
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →